Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025
Table of contents
Date:
06/12/2018
Location:
European Medicines Agency, London, UK
This multi-stakeholder workshop aims to gather initial thoughts on the key areas to be covered in the current reflection on EMA’s Regulatory Science to 2025 and will share proposals for veterinary medicines.
This aims to facilitate:
- a shared reflection on the key regulatory science faced by the various scientific committees and working parties of the Agency and opportunities to address these;
- an understanding of the process by which the proposed strategic goals and core recommendations were elaborated to date;
- highlight areas of particular relevance to various stakeholder groups to focus on during the public consultation.
The participants will include veterinarians, academic infrastructures, trade associations and regulators.
The event is by invitation-only to allow for a fair distribution across stakeholders.
It will be broadcast live which interested parties can follow on this page. The recording will be available after the workshop.
-
List item
Agenda - Regulatory science to 2025: launch of veterinary stakeholder consultation (PDF/743.53 KB)
Draft
First published: 29/11/2018
Last updated: 03/12/2018
EMA/780555/2018 -
List item
Presentation - Session 1: Regulation of veterinary medicinal products in the 21st century: addressing challenges and opportunities across the European Regulatory Framework (Ivo Claassen) (PDF/480.52 KB)
First published: 11/01/2019 -
List item
Presentation - Session 1: Integration of Agency Committees and Network into delivery of the strategy (David Murphy) (PDF/366.2 KB)
First published: 11/01/2019 -
List item
Presentation - Session 1: Regulatory Science to 2025: view from the European Commission (Christian Siebert) (PDF/291.87 KB)
First published: 11/01/2019 -
List item
Presentation - Session 1: View from European Medicines Regulatory Network (Jean-Pierre Orand) (PDF/957.32 KB)
First published: 11/01/2019 -
List item
Presentation - Session 1: Challenges and opportunities across theregulatory framework: view from veterinarians (Nancy De Briyne) (PDF/887.91 KB)
First published: 11/01/2019 -
List item
Presentation - Session 1: Challenges and opportunities across the European Regulatory Framework: view for the animal medicines industry (Alexander Böttner) (PDF/318.99 KB)
First published: 11/01/2019 -
List item
Presentation - Session 2: Veterinary vaccines: proposal to facilitate licensing in general (Carmen Jungbaeck) (PDF/51.5 KB)
First published: 11/01/2019 -
List item
Presentation - Session 2: Catalysing the integration of science and technology in drug development (Rory Breathnach) (PDF/486.09 KB)
First published: 11/01/2019 -
List item
Presentation - Session 2: Catalysing the integration of science and technology in development (Jackie Atkinson) (PDF/48.03 KB)
First published: 11/01/2019 -
List item
Presentation - Session 2: Association of Veterinary Consultants (Klaus Hellmann) (PDF/141.7 KB)
First published: 11/01/2019 -
List item
Presentation - Session 2: RS to 2025: catalysing the integration of science and technology in drug development (Lindsay Marshall) (PDF/196.25 KB)
First published: 11/01/2019 -
List item
Presentation - Session 3: Driving collaborative evidence generation and improving the scientific quality of evaluations (Nicholas Jarrett) (PDF/1.05 MB)
First published: 11/01/2019 -
List item
Presentation - Veterinary Stakeholders Workshop: European Group for Generic Veterinary Products (EGGVP) (Elsa Vecino) (PDF/99.66 KB)
First published: 11/01/2019 -
List item
Presentation - Session 3: Driving collaborative evidence generation: improving the scientific quality of evaluations (Jaques Lechenet) (PDF/41.77 KB)
First published: 11/01/2019 -
List item
Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Helen Jukes) (PDF/665.45 KB)
First published: 11/01/2019 -
List item
Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Alexander Boettner) (PDF/37.67 KB)
First published: 11/01/2019 -
List item
Presentation - Session 4: Veterinary vaccines: proposal to facilitate licensing in exceptional circumstances (emergency) (Carmen Jungbaeck) (PDF/28.21 KB)
First published: 11/01/2019 -
List item
Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Georg von Samson-Himmelstjerna) (PDF/87.45 KB)
First published: 11/01/2019 -
List item
Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Rens van Dobbenburgh) (PDF/496.75 KB)
First published: 11/01/2019 -
List item
Presentation - Session 5: Enabling and leveraging research and innovation in regulatory science (Tony Humphreys) (PDF/530.88 KB)
First published: 11/01/2019